Cheng Shen

749 total citations
35 papers, 547 citations indexed

About

Cheng Shen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Cheng Shen has authored 35 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Cheng Shen's work include Cardiovascular Function and Risk Factors (6 papers), Alcohol Consumption and Health Effects (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Cheng Shen is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Alcohol Consumption and Health Effects (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Cheng Shen collaborates with scholars based in China, United States and Germany. Cheng Shen's co-authors include Kai Hu, Aijun Sun, Junbo Ge, Wenjia Li, Lei Yin, Junbo Ge, Xin Ma, Jinguo Zhang, Zhen Dong and Cong Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Cheng Shen

32 papers receiving 539 citations

Peers

Cheng Shen
Nassrene Y. Elmadhun United States
Mitchell E. Allen United States
Katharina Pfeil Germany
Lihan Sun China
Mingjie Yang China
Dajun Zhao China
Renee Wong United States
Maria Kátia Gomes Brazil
Ariel H. Polizio Argentina
Bharat P. Jaishy United States
Nassrene Y. Elmadhun United States
Cheng Shen
Citations per year, relative to Cheng Shen Cheng Shen (= 1×) peers Nassrene Y. Elmadhun

Countries citing papers authored by Cheng Shen

Since Specialization
Citations

This map shows the geographic impact of Cheng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Shen more than expected).

Fields of papers citing papers by Cheng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Shen. The network helps show where Cheng Shen may publish in the future.

Co-authorship network of co-authors of Cheng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Shen. A scholar is included among the top collaborators of Cheng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Shen. Cheng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhongyan, Qi Zhou, Zhenchong Li, et al.. (2025). DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma. Drug Resistance Updates. 81. 101224–101224. 4 indexed citations
2.
Guo, Chang-Run, Jiyuan Li, Tiantian Li, et al.. (2025). Understanding interspecies drug response variations between human and rodent P2X7 receptors. Nature Communications. 16(1). 10827–10827. 1 indexed citations
3.
Zhang, Shuang, et al.. (2025). Myocardial infarction with nonobstructive coronary arteries (MINOCA): a narrative review. European journal of medical research. 30(1). 443–443.
4.
Gao, Ge, Cheng Shen, Manman Wang, et al.. (2025). Liraglutide attenuates doxorubicin-induced cardiomyocyte ferroptosis via DHHC7-mediated STAT3 palmitoylation. Life Sciences. 379. 123912–123912. 1 indexed citations
5.
Wang, Jinlin, et al.. (2025). Effect of obesity on cardiovascular morphofunctional phenotype: Study of Mendelian randomization. Medicine. 104(13). e41858–e41858.
6.
Jin, Fei, Ruiqi Rachel Wang, Cheng Shen, et al.. (2024). Cryo-EM structure of the zinc-activated channel (ZAC) in the Cys-loop receptor superfamily. Proceedings of the National Academy of Sciences. 121(44). e2405659121–e2405659121. 3 indexed citations
7.
Lin, Lizhi, et al.. (2023). Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease. Stem Cells International. 2023. 1–20. 5 indexed citations
8.
Shen, Cheng, Lei Xu, Xiaoning Sun, Aijun Sun, & Junbo Ge. (2022). Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study. Annals of Translational Medicine. 10(3). 129–129. 13 indexed citations
9.
Shen, Cheng, Chen Chen, & Liling Wang. (2022). Gelsemine Exerts Neuroprotective Effects on Neonatal Mice with Hypoxic-Ischemic Brain Injury by Suppressing Inflammation and Oxidative Stress via Nrf2/HO-1 Pathway. Neurochemical Research. 48(5). 1305–1319. 14 indexed citations
10.
11.
Zhang, Zhiqiang, Lei Chen, Chao Tian, et al.. (2022). Exosomes derived from human umbilical cord mesenchymal stem cells (HUCMSC-EXO) regulate autophagy through AMPK-ULK1 signaling pathway to ameliorate diabetic cardiomyopathy. Biochemical and Biophysical Research Communications. 632. 195–203. 18 indexed citations
12.
Meng, Fanjing, et al.. (2019). Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–16. 49 indexed citations
13.
Li, Wenjia, Lei Yin, Cheng Shen, et al.. (2018). SCN5A Variants: Association With Cardiac Disorders. Frontiers in Physiology. 9. 1372–1372. 95 indexed citations
14.
Shen, Cheng, Cong Wang, Shasha Han, et al.. (2016). Aldehyde dehydrogenase 2 deficiency negates chronic low-to-moderate alcohol consumption-induced cardioprotecion possibly via ROS-dependent apoptosis and RIP1/RIP3/MLKL-mediated necroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(8). 1912–1918. 37 indexed citations
15.
Wang, Shifeng, Qiao Zhang, Yuxin Zhang, et al.. (2016). Agrimol B suppresses adipogenesis through modulation of SIRT1-PPAR gamma signal pathway. Biochemical and Biophysical Research Communications. 477(3). 454–460. 26 indexed citations
16.
Wang, Cong, Fan Fan, Cheng Shen, et al.. (2016). Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice. Journal of Molecular Medicine. 94(11). 1229–1240. 39 indexed citations
17.
Hu, Yijie, Qi‐Jian Sun, Zhiping Li, et al.. (2014). High basal level of autophagy in high-altitude residents attenuates myocardial ischemia–reperfusion injury. Journal of Thoracic and Cardiovascular Surgery. 148(4). 1674–1680. 21 indexed citations
18.
Shen, Cheng, Cong Wang, Fan Fan, et al.. (2014). Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(2). 310–318. 36 indexed citations
19.
Fan, Fan, Cong Wang, Xin Ma, et al.. (2014). Impact of chronic low to moderate alcohol consumption on blood lipid and heart energy profile in acetaldehyde dehydrogenase 2-deficient mice. Acta Pharmacologica Sinica. 35(8). 1015–1022. 18 indexed citations
20.
Shen, Cheng. (2005). The Establishment of A New Model of Rat Coronary Microthrombosis by Coronary Sodium Laurate Injection. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nassrene Y. Elmadhun Breakdown of academic impact, for papers by Mitchell E. Allen Breakdown of academic impact, for papers by Katharina Pfeil Breakdown of academic impact, for papers by Lihan Sun Breakdown of academic impact, for papers by Mingjie Yang Breakdown of academic impact, for papers by Dajun Zhao Breakdown of academic impact, for papers by Renee Wong Breakdown of academic impact, for papers by Maria Kátia Gomes Breakdown of academic impact, for papers by Ariel H. Polizio Breakdown of academic impact, for papers by Bharat P. Jaishy
Rankless by CCL
2026